Overview
Lithium is a soft, silvery alkali metal and the lightest solid element, widely recognized in medicine as one of the oldest and most effective mood stabilizers. It is extensively used in the treatment and long-term management of bipolar affective disorder. It helps control manic episodes, prevents depressive relapses, and reduces aggression, impulsivity, and suicidal behavior. Its therapeutic action is linked to the regulation of neurotransmitters, intracellular signaling pathways, and neuronal plasticity. Because lithium has a narrow therapeutic index, careful monitoring of blood levels is essential to ensure efficacy while avoiding toxicity.
Symptoms
It itself does not cause symptoms when maintained within the therapeutic range. However, abnormal levels may lead to clinical manifestations. Subtherapeutic levels can result in poor symptom control, including recurrence of manic or depressive episodes. Elevated lithium levels may cause gastrointestinal symptoms, neurological disturbances, tremors, confusion, and, in severe cases, renal and neurological complications. Monitoring helps detect early signs of imbalance before significant clinical symptoms develop.
Causes
Abnormal lithium levels are influenced by several physiological and external factors. Dehydration, vomiting, diarrhea, fever, excessive sweating, and low sodium intake can increase lithium concentration. Renal impairment reduces lithium clearance and is a major cause of elevated levels. Drug interactions, especially with diuretics, nonsteroidal anti-inflammatory drugs, angiotensin converting enzyme inhibitors, and certain antibiotics, can significantly raise these levels. Overdose, either acute or chronic, also leads to toxicity. Low lithium levels may occur due to poor compliance, underdosing, increased renal clearance, or drug interactions that reduce absorption or increase excretion.
Risk Factors
Risk factors for lithium imbalance include impaired kidney function, dehydration, advancing age, chronic medical conditions such as hypertension or diabetes, and concurrent use of interacting medications. Variations in hydration status, sodium intake, and daily dosing schedules also affect serum levels. Because this is eliminated primarily through the kidneys, any condition altering renal function increases the risk of toxicity. Diurnal variation and improper sample timing can further complicate interpretation.
Prevention
Prevention of toxicity relies on regular therapeutic drug monitoring and proper sample collection. Blood samples should be collected approximately twelve hours after the last dose, ideally in the morning before the next scheduled dose. Patients should maintain adequate hydration and consistent dietary sodium intake. Awareness of potential drug interactions and periodic assessment of renal function are essential. Appropriate dose titration guided by serial serum lithium measurements ensures safe and effective long-term therapy while minimizing adverse effects.
